IQT (In-Q-Tel)’s Post

Many of the circles I run in are full of biotech experts, but it’s important to broaden the audience and understanding of what is so important about the advancements happening in the field right now. So if you’re curious about #biotech and #ai, check it out. Thanks Eugene Chiu and Farid N. for the conversation.

Something on the 👂 : Joel Eichmann invited me to his super interesting podcast series Doppelhelix 🧬. We had a chat about our startup and the technology behind. Maybe better to listen than being bored on a foggy cold November weekend?😶🌫️ Language is German.🇩🇪 Joel is co-founder at Green Elephant Biotech, a company revolutionizing lab supplies by reducing the carbon footprint of single use consumables like micotiterplates, which are crucial for our seedalive GmbH #seedviability rapid test, by 50% ⏬! How do they achieve that? By replacing crude oil based plastics by plant based materials. „The world’s first plant based 96-well plates“! 💪WOW! We at seedalive always try to be at the forefront of new ressource-saving developments and acknowledge the developments in the area of labconsumables, just like our technology saves 99% energy compared to the established method. If we all go small steps in the right direction in every aspect of our business and daily life big changes are possible! And we urgently need big changes as we all know! Thanks for having me, Joel! Nature is so cool, humans not all!🇺🇦 Franziska Gröne Lena Fell Klaus Mummenhoff Felix Wollenhaupt #seedalive #nevereveragainisnow #standwithukrain (now more than ever!)

Why don’t single-protein #biomarkers cut it in biological research? In a new episode of “Translating Proteomics,” our Co-Founder and Chief Scientist Parag Mallick and Senior Director of Scientific Affairs and Alliance Management Andreas Huhmer discuss the challenges faced when finding new biomarkers and propose a variety of ways to accelerate discovery of multi-protein, multi-time point, and even multiomic biomarkers. Learn why these biomarkers could have more potential than any single protein measurement by visiting our website or the streaming platforms below: https://lnkd.in/gANUdqAA 🎧 Apple Podcasts: https://lnkd.in/gET59DHx   🎧 Spotify: https://lnkd.in/gTR4by-Q   📺 YouTube: https://lnkd.in/gwXpKQ5h  #BiomarkerDiscovery #Proteomics #UnleashTheProteome #ProteomicsRevolution #SingleMolecule #MassSpectrometry #TeamMassSpec #Biotech

Protein #biomarkers are critical to improving all aspects of the continuum of care. With the right biomarkers, we will be better able to track 'healthy,' predict disease onset, monitor treatment effectiveness, and conduct well-informed follow-up. In the latest episode of Translating Proteomics, Andreas Huhmer and I discuss why searching for circulating protein biomarkers is challenging and what will be needed to drive advances in biomarker discovery. One topic we discuss deeply is our need, as a community, to transition away from thinking of biomarkers as single proteins measured at single time points and instead towards biomarkers as serial measurements of sets of proteins. Using single-time-point, single-protein biomarkers to understand someone's health is akin to looking at a single note on a piece of sheet music and trying to identify the song. Wouldn't it be easier if we could look at many chords across many phrases? Come join the conversation!

What’s it really like to build a biotech company from scratch? 🤔 On last week's episode of The Genetics Podcast, Patrick chatted with Dr. Nessan Bermingham, a biotech pioneer who has s co-founded companies like Intellia Therapeutics and Korro Bio. He talks about the challenges of bringing CRISPR and RNA editing technologies to life, navigating funding and regulatory hurdles, and why AI might not be the game-changer many hope for (yet). Read a quick recap or listen in full 👉 https://lnkd.in/eZQfWp7Z #Biotech #CRISPR #PrecisionMedicine

“Driving Training Workflows with Tribal Knowledge - with Brenda (Friesenhahn) Kahl of Illumina” https://lnkd.in/d_MacVm Brenda (Friesenhahn) Kahl, Senior Director of Service and Support at Illumina, joins today's program to discuss training challenges in field service operations within the biotech industry. Illumina, a San Diego-based biotechnology company founded in 1998, develops and markets systems for genetic analysis. Their products serve the sequencing, genotyping, gene expression, and proteomics markets across more than 155 countries. During the episode, Brenda provides valuable insights into the technology infrastructure necessary for building effective solutions. She highlights strategies for improving efficiency and reducing costs using call center metrics and digital tools. These tools include tribal knowledge systems designed to accommodate new working styles, such as remote work. Brenda's expertise offers actionable advice for professionals aiming to optimize their field service operations. Her emphasis on leveraging technology to drive improvements is particularly relevant in today's rapidly evolving biotech landscape. #Biotechnology #GeneticAnalysis #FieldService #Efficiency #CostSavings #CallCenterMetrics #DigitalTools #RemoteWork #TrainingChallenges #TechnologyInfrastructure #Illumina #BiotechSolutions #ProfessionalDevelopment #TechInnovation #OperationalExcellence

Innovation in Action at CellClar 🚀 At CellClar, we’re not just building biotech solutions; we’re building bridges to a better future. Co-Founded by our CEO, Mo, our mission is to break the mold of the traditional corporate biotech and operate with transparency, authenticity, and community in mind. We believe in co-creating a future where science not only understands complex diseases but rewires them for health. That’s why we’re excited to share a glimpse of the ground-breaking features currently in development for our latest product, SC BioModelling: 🔬 Generate Gene Regulatory Networks (GRNs): Harness the power of single-cell transcriptomics & proteomics to correlate mRNA and protein or explore the interplay between transcriptomics and epigenomics. 💡 Rewire Networks Using In-Silico Modelling: Imagine the transformation—disease state to healthy state—through advanced computational insights. 📈 Model Disease Progression: Predict the dynamics of novel target gene expression as diseases progress, enabling a deeper understanding and better therapeutic strategies. While these innovations are still under development, we’re more committed than ever to driving forward and making an impact. But we know that real progress doesn’t happen in isolation. That’s why we’re inviting you to join us: 👉 Are you passionate about advancing biotech? 👉 Interested in partnering with us on this transformative journey? 👉 Want to beta-test SC BioModelling when it’s ready? Let’s connect! Comment below or DM Mohammed El-Gasim directly to explore how we can work together to create a healthier future for all. #BiotechInnovation #SingleCellResearch #CommunityScience #CellClar #GeneRegulation #DiseaseModeling #ComputationalBiology #Epigenomics #Proteomics #LifeSciences #HealthTech #FutureOfMedicine #PrecisionMedicine #InSilicoModeling #DrugDiscovery #BiotechCommunity

Join us for an exciting evening of engaging discussions at Pub St. Paul in the Old Port! Our "Hot Topics" networking event features six tables, each hosting a dynamic conversation on a different hot topic. Moderators will kick off the discussions, and you'll have the opportunity to circulate between tables of your choice in a speed-dating format, diving into the topics that spark your curiosity the most. The evening will also include time for general networking. Food and drink will be served. Don’t miss this chance to connect, learn, and exchange ideas in a relaxed, vibrant atmosphere! Discussion topics will include: Trends in Pharma: new drug areas, what is working well, and points of concern The Current State of Gene Therapy / Gene Editing: from basic science to commercialization Manufacturing: big investment and pressing issues Reimbursement: the key to a successful therapy launch Building Healthy and Effective Teams: hiring, retention, and development Open: based on attendee interest Appetizer-style food and drinks will be served. Register here : https://lnkd.in/eNGHyf4Y #WomenInBio #BioWomenEmpowerment #WomenInScience #WomenLeadingBio #BioWomenNetwork #WomenInSTEM #EmpowerHerInBio #FemalesInBiotech #WomenInResearch #SheLeadsInBio

Howard’s career started with a patient who nearly died… During his training, Howard McLeod discovered a gene causing a severe reaction to a common therapy. As a result, he pursued precision medicine, exploring why people respond differently to drugs. Now, with decades of experience, Howard is a top expert in the field, working with FDA, advising companies and teaching at university on the topic. Watch the full podcast episode here to learn Howard’s journey: https://lnkd.in/dM24Vrdg Have you experienced an event that pushed your career in a specific direction?

The BioAge podcast, Translating Aging, features the people & companies advancing the science of human longevity and discovering drugs to extend healthspan. Our newest episode just dropped!